Insights

Loading spinner
Gathering insights about MBF Therapeutics Inc.

MBF Therapeutics Inc. Tech Stack

MBF Therapeutics Inc. uses 8 technology products and services including Unpkg, TweenMax, React, and more. Explore MBF Therapeutics Inc.'s tech stack below.

  • Unpkg
    Content Delivery Network
  • TweenMax
    Javascript Frameworks
  • React
    Javascript Frameworks
  • Zepto
    Javascript Libraries
  • Lodash
    Javascript Libraries
  • PHP
    Programming Languages
  • Bluehost
    Web Hosting
  • Apache HTTP Server
    Web Servers

Media & News

MBF Therapeutics Inc.'s Email Address Formats

MBF Therapeutics Inc. uses at least 1 format(s):
MBF Therapeutics Inc. Email FormatsExamplePercentage
FLast@mbftherapeutics.comJDoe@mbftherapeutics.com
50%
FLast@mbftherapeutics.comJDoe@mbftherapeutics.com
50%

Frequently Asked Questions

What is MBF Therapeutics Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact MBF Therapeutics Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MBF Therapeutics Inc.'s official website and social media links?

Minus sign iconPlus sign icon
MBF Therapeutics Inc.'s official website is mbftherapeutics.com and has social profiles on LinkedInCrunchbase.

What is MBF Therapeutics Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
MBF Therapeutics Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MBF Therapeutics Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, MBF Therapeutics Inc. has approximately 8 employees across 2 continents, including North AmericaEurope. Key team members include Ceo & President: T. T.Cso: L. K.Chief Medical Officer: R. C.. Explore MBF Therapeutics Inc.'s employee directory with LeadIQ.

What industry does MBF Therapeutics Inc. belong to?

Minus sign iconPlus sign icon
MBF Therapeutics Inc. operates in the Biotechnology Research industry.

What technology does MBF Therapeutics Inc. use?

Minus sign iconPlus sign icon
MBF Therapeutics Inc.'s tech stack includes UnpkgTweenMaxReactZeptoLodashPHPBluehostApache HTTP Server.

What is MBF Therapeutics Inc.'s email format?

Minus sign iconPlus sign icon
MBF Therapeutics Inc.'s email format typically follows the pattern of FLast@mbftherapeutics.com. Find more MBF Therapeutics Inc. email formats with LeadIQ.

How much funding has MBF Therapeutics Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, MBF Therapeutics Inc. has raised $256K in funding. The last funding round occurred on Dec 21, 2021 for $256K.

When was MBF Therapeutics Inc. founded?

Minus sign iconPlus sign icon
MBF Therapeutics Inc. was founded in 2008.

MBF Therapeutics Inc.

Biotechnology ResearchUnited States2-10 Employees

MBF Therapeutics is an immunotherapeutics company focused on animal applications of its innovative T-Max™ immunotherapeutic DNA vaccine platform. In addition, there are significant translational opportunities in human health. Our T-Max platform addresses longstanding shortcomings of traditional viral vaccine technologies based primarily on killed/inactivated (KWV) whole virus or modified live/attenuated virus vaccines (MLV/AV). Killed virus vaccines have been fairly safe but not efficacious, while MLV vaccine must replicate to generate reasonable efficacy and therefore have significant safety issues for the vaccinated animal and also the herd because of chronic carriers and viral shedding. MBFT will create safe and efficacious vaccines focused on respiratory viral diseases that cause significant negative economic and social impacts.  Specifically Porcine Reproductive and Respiratory Syndrome (PRRS) considered the most economically significant disease of worldwide swine production; and African Swine Fever (ASF), a highly fatal and reportable disease that has caused billions of dollars lost due to death/cull of millions of pigs and disrupted markets and trade throughout Asia, Europe, Africa and now threatens the US with an estimated cost impact of 50 billion dollars in lost trade and containment costs.
T-Max Plasmid DNA Vaccine Platform
MBFT’s T-Max™ DNA vaccine platform is a proprietary process from discovery to commercialization of protective vaccines that identifies clinically relevant pathogen antigens and delivers them in proprietary formulations to stimulate durable and potent T cell immune responses.  Four components differentiate the platform:  
1. Novel antigen selection process to identify multiple clinically relevant antigens to create cross-protective ”universal” vaccines; 
2. Cloning into proprietary plasmids containing a non-antibiotic selection system; 
3. One or more immunomodulators that stimulate a strong innate immune response; and 
4. CaptaVa

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2008
Employees
2-10

Section iconFunding & Financials

  • $256K

    MBF Therapeutics Inc. has raised a total of $256K of funding over 4 rounds. Their latest funding round was raised on Dec 21, 2021 in the amount of $256K.

  • $1M$10M

    MBF Therapeutics Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $256K

    MBF Therapeutics Inc. has raised a total of $256K of funding over 4 rounds. Their latest funding round was raised on Dec 21, 2021 in the amount of $256K.

  • $1M$10M

    MBF Therapeutics Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.